KING OF PRUSSIA, Pa., April 10, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2024, after the market closes on Wednesday, April 24, 2024. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Thursday, April 25, 2024.
A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.
Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico.
| Last Trade: | US$180.11 |
| Daily Change: | 4.31 2.45 |
| Daily Volume: | 985,203 |
| Market Cap: | US$10.570B |
October 29, 2024 June 07, 2024 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
